pindolol [Ligand Id: 91] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL500 (Apo-pindol, Betadren, Betapindol, Blocklin-l, Calvisken, Carvisken, Decreten, Dl-lb-46, Dl-pindolol, Durapindol, Glauco-visken, LB-46, NSC-757276, Pectobloc, Pinbetol, Pindolol, Prinodolol, Pynastin, (rs)-pindolol, Visken)
  • β1-adrenoceptor/Beta-1 adrenergic receptor in Human [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
There should be some charts here, you may need to enable JavaScript!
  • β2-adrenoceptor/Beta-2 adrenergic receptor in Human [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
There should be some charts here, you may need to enable JavaScript!
  • β3-adrenoceptor/Beta-3 adrenergic receptor in Human [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
There should be some charts here, you may need to enable JavaScript!
  • 5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908]
  • 5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Rat [ChEMBL: CHEMBL273] [GtoPdb: 1] [UniProtKB: P19327]
There should be some charts here, you may need to enable JavaScript!
  • 5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Human [ChEMBL: CHEMBL1898] [GtoPdb: 2] [UniProtKB: P28222]
  • 5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Rat [ChEMBL: CHEMBL3459] [GtoPdb: 2] [UniProtKB: P28564]
There should be some charts here, you may need to enable JavaScript!
  • 5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
  • 5-HT2A receptor in Human [GtoPdb: 6] [UniProtKB: P28223]
There should be some charts here, you may need to enable JavaScript!
  • 5-HT2B receptor in Human [GtoPdb: 7] [UniProtKB: P41595]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
ChEMBL Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis F 5 pKd <10000 nM Kd J Med Chem (2011) 54: 6874-6887 [PMID:21870877]
ChEMBL Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells B 8.58 pKd 2.63 nM Kd J Med Chem (2011) 54: 6874-6887 [PMID:21870877]
ChEMBL Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis F 8.62 pKd 2.4 nM Kd J Med Chem (2011) 54: 6874-6887 [PMID:21870877]
ChEMBL DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) B 9.27 pKi 0.53 nM Ki DrugMatrix in vitro pharmacology data
ChEMBL Binding affinity at human adrenergic beta-1 receptor B 9.28 pKi 0.52 nM Ki Bioorg Med Chem Lett (2007) 17: 5600-5604 [PMID:17804228]
GtoPdb - - 9.3 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Bioorg Med Chem Lett (2007) 17: 5600-4 [PMID:17804228]
GtoPdb - - 9.7 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 525-32 [PMID:15060759];
Mol Pharmacol (2003) 64: 1357-69 [PMID:14645666];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
ChEMBL DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) B 9.04 pIC50 0.92 nM IC50 DrugMatrix in vitro pharmacology data
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
ChEMBL Antagonist activity at human beta-2 adrenergic receptor expressed in salbutamol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis F 9.18 pKd 0.66 nM Kd J Med Chem (2011) 54: 6874-6887 [PMID:21870877]
ChEMBL Displacement of [3H]-CGP 12177 from human beta-2 adrenergic receptor expressed in CHOK1 cells B 9.27 pKd 0.54 nM Kd J Med Chem (2011) 54: 6874-6887 [PMID:21870877]
ChEMBL Binding affinity at human adrenergic beta2 receptor B 9.4 pKi 0.4 nM Ki Bioorg Med Chem Lett (2007) 17: 5600-5604 [PMID:17804228]
GtoPdb - - 9.4 pKi - - - Bioorg Med Chem Lett (2007) 17: 5600-4 [PMID:17804228]
GtoPdb - - 9.4 pKi 0.4 nM Ki Bioorg Med Chem Lett (2007) 17: 5600-4 [PMID:17804228]
ChEMBL DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) B 9.42 pKi 0.38 nM Ki DrugMatrix in vitro pharmacology data
ChEMBL DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) B 9.26 pIC50 0.55 nM IC50 DrugMatrix in vitro pharmacology data
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
ChEMBL Antagonist activity at human beta-3 adrenergic receptor expressed in fenoterol-stimulated CHOK1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis F 6 pKd <1000 nM Kd J Med Chem (2011) 54: 6874-6887 [PMID:21870877]
ChEMBL Displacement of [3H]-CGP 12177 from human beta-3 adrenergic receptor expressed in CHOK1 cells B 6.78 pKd 165.96 nM Kd J Med Chem (2011) 54: 6874-6887 [PMID:21870877]
GtoPdb - - 7.1 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
ChEMBL DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) B 7.18 pKi 66 nM Ki DrugMatrix in vitro pharmacology data
ChEMBL DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) B 7.06 pIC50 88 nM IC50 DrugMatrix in vitro pharmacology data
GtoPdb - - 7.4 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908]
ChEMBL Binding affinity to 5HT1A receptor B 7.2 pKd 63.1 nM Kd J Med Chem (2009) 52: 6107-6125 [PMID:19754201]
ChEMBL Inhibition constant against 5-hydroxytryptamine 1A receptor B 6.96 pKi 110 nM Ki J Med Chem (2005) 48: 6523-6543 [PMID:16220969]
ChEMBL Antagonist activity at human 5HT1A expressed in mouse LM(tK-) cells assessed as inhibition of 5-HT-stimulated [35S]GTP-gamma-S binding F 7.09 pKi 81.1 nM Ki Bioorg Med Chem Lett (2007) 17: 5600-5604 [PMID:17804228]
ChEMBL Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells B 7.62 pKi 24 nM Ki Bioorg Med Chem Lett (1999) 9: 3243-3248 [PMID:10576696]
ChEMBL Displacement of [3H]DPAT from human 5HT1A receptor B 7.65 pKi 22.4 nM Ki Bioorg Med Chem Lett (2007) 17: 5600-5604 [PMID:17804228]
GtoPdb - - 8.1 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 205-17 [PMID:9550290]
ChEMBL Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells B 7.57 pEC50 27 nM EC50 Bioorg Med Chem Lett (1999) 9: 3243-3248 [PMID:10576696]
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL273] [GtoPdb: 1] [UniProtKB: P19327]
ChEMBL DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) B 7.57 pKi 27 nM Ki DrugMatrix in vitro pharmacology data
ChEMBL Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement B 7.66 pKi 21.88 nM Ki J Med Chem (1996) 39: 126-134 [PMID:8568799]
ChEMBL Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand. B 7.7 pKi 20 nM Ki J Med Chem (1987) 30: 1-12 [PMID:3543362]
ChEMBL DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) B 7.32 pIC50 48 nM IC50 DrugMatrix in vitro pharmacology data
5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1898] [GtoPdb: 2] [UniProtKB: P28222]
ChEMBL Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor F 5 pKi >10000 nM Ki J Med Chem (1997) 40: 4415-4419 [PMID:9435911]
ChEMBL Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor F 5.59 pKi 2600 nM Ki J Med Chem (1997) 40: 4415-4419 [PMID:9435911]
5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3459] [GtoPdb: 2] [UniProtKB: P28564]
ChEMBL Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand. B 7.1 pKi 80 nM Ki J Med Chem (1987) 30: 1-12 [PMID:3543362]
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335]
ChEMBL Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand. B 4.27 pKi 54000 nM Ki J Med Chem (1987) 30: 1-12 [PMID:3543362]
SERT/Serotonin transporter in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL313] [GtoPdb: 928] [UniProtKB: P31652]
ChEMBL Displacement of specific [3H]- citalopram binding to 5-HT uptake site in rat whole cortex B 5.15 pKi >7000 nM Ki Bioorg Med Chem Lett (1999) 9: 3243-3248 [PMID:10576696]
5-HT2A receptor in Human [GtoPdb: 6] [UniProtKB: P28223]
GtoPdb - - 5 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]
GtoPdb - - 5 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]
5-HT2B receptor in Human [GtoPdb: 7] [UniProtKB: P41595]
GtoPdb - - 5.7 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]
GtoPdb - - 5.7 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 370: 114-23 [PMID:15322733]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]